In Stock
Olmesartan Medoxomil Tablets
Olmesartan Medoxomil Tablets 20mg | Cardiac / Hypertension
- Product Form: Raw Powder / API
- Not for direct consumer use
- For qualified buyers, formulation, compounding, R&D, and regulated business use only
- COA/MSDS available upon request
- Final sale depends on buyer country import regulations
Disclaimer: Products listed on this website are intended for qualified business buyers, research, formulation, compounding, or regulated pharmaceutical use only. Products are not intended for direct consumer use. Import permission, registration, customs clearance, and local regulatory compliance are the responsibility of the buyer in their respective country.
Description
This document provides concise, practical information about Olmesartan Medoxomil 20 mg presented as a generic product information sheet. It covers product introduction, clinical uses, benefits, common side effects, safety advice, mechanism of action, directions for use, quick tips for patients, and important drug interactions. This material is intended for informational purposes only and does not replace professional medical advice.
Product Introduction
Olmesartan medoxomil is an angiotensin II receptor blocker (ARB) used primarily to treat high blood pressure (hypertension). The active ingredient is converted in the body to olmesartan, which selectively blocks the binding of angiotensin II to the AT1 receptor. The usual generic tablet strength includes 20 mg of olmesartan (as olmesartan medoxomil). It is prescribed to lower blood pressure, reduce the risk of cardiovascular events related to hypertension, and help protect kidney function in certain patients.
Uses
-
Primary therapy for essential (primary) hypertension to lower elevated blood pressure.
-
Adjunct therapy to reduce cardiovascular risk associated with uncontrolled hypertension.
-
May be used to slow progression of kidney damage in patients with certain conditions, when clinically indicated.
-
Used as part of combination therapy with other antihypertensive agents when monotherapy is insufficient.
Benefits
-
Effective blood pressure reduction leading to lower risk of stroke, heart attack, and heart failure.
-
Generally well tolerated compared with some other antihypertensive classes (for example, fewer cough complaints than ACE inhibitors).
-
Once-daily dosing provides sustained blood pressure control for most patients.
-
Can be combined safely with many other antihypertensive medications to achieve target blood pressure.
Side Effects
Common side effects are usually mild and may include dizziness, headache, fatigue, and gastrointestinal symptoms such as nausea. Some patients may experience:
-
Dizziness or lightheadedness, particularly after the first dose or when standing up quickly.
-
Headache.
-
Gastrointestinal discomfort (nausea, abdominal pain, diarrhea).
-
Fatigue or asthenia.
-
Less commonly, elevated blood potassium (hyperkalemia) or changes in kidney function.
Serious but rare adverse reactions include severe hypotension, acute kidney injury, and angioedema (swelling of face, lips, tongue, or throat), which requires immediate medical attention. If any signs of severe allergic reaction or difficulty breathing occur, stop the medication and seek emergency care.
Safety Advice
-
Do not use during pregnancy: ARBs like olmesartan can cause fetal harm (including injury and death to the developing fetus). Women of childbearing potential should use effective contraception; if pregnancy is detected, discontinue immediately and inform the healthcare provider.
-
Avoid use in patients with severe bilateral renal artery stenosis or confirmed hypersensitivity to olmesartan or any tablet excipients.
-
Caution in patients with impaired renal function: monitoring of serum creatinine and potassium is recommended when initiating or increasing dose.
-
Use caution if combining with potassium-sparing diuretics, potassium supplements, or potassium-containing salt substitutes because of the risk of hyperkalemia.
-
Elderly patients may be more sensitive to blood pressure-lowering effects; start at lower doses and monitor for orthostatic hypotension.
-
Inform your healthcare provider about all medical conditions, especially heart problems, kidney disease, dehydration, and electrolyte disturbances.
How It Works
Olmesartan medoxomil is a prodrug that is converted to olmesartan after oral administration. Olmesartan selectively blocks the angiotensin II type 1 (AT1) receptor, preventing angiotensin II from causing vasoconstriction and aldosterone release. By blocking these effects, olmesartan causes vasodilation (widening of blood vessels), reduces sodium and water retention, and lowers systemic vascular resistance—collectively reducing blood pressure.
How to Use
Always follow the prescribing doctor’s instructions. Typical guidance for adults:
-
Dose: The common starting dose is 20 mg once daily, but the exact dose and titration depend on the patient’s baseline blood pressure, response, and clinical factors.
-
Administration: Take the tablet once daily with or without food at the same time each day to maintain consistent blood levels.
-
Missed dose: If a dose is missed, take it as soon as remembered on the same day. Do not double the next dose to make up for the missed one.
-
Duration: Antihypertensive therapy is usually long-term. Do not stop taking olmesartan without consulting the prescribing clinician; abrupt discontinuation may destabilize blood pressure control.
Quick Tips
-
Measure blood pressure regularly, at home if possible, and keep a record to discuss with your clinician.
-
Stand up slowly from sitting or lying positions to reduce dizziness or lightheadedness.
-
Avoid excessive alcohol while on antihypertensives, as it can increase blood pressure-lowering effects and cause dizziness.
-
Maintain a heart-healthy lifestyle: reduced salt intake, balanced diet, regular exercise, smoking cessation, and weight management enhance medication benefits.
-
Carry a list of current medications to check for interactions when seeing other healthcare providers or pharmacists.
Drug Interactions
Olmesartan can interact with several medications and supplements. Important interactions include:
-
Potassium-sparing diuretics (e.g., spironolactone), potassium supplements, or potassium-containing salt substitutes: increased risk of hyperkalemia.
-
Other agents that raise potassium (e.g., ACE inhibitors): combined use increases hyperkalemia and renal impairment risk; concurrent use is generally avoided or carefully monitored.
-
Nonsteroidal anti-inflammatory drugs (NSAIDs): may reduce antihypertensive effect and increase risk of kidney function deterioration, especially in volume-depleted patients or those with preexisting renal impairment.
-
Lithium: ARBs can increase lithium levels and toxicity; monitor lithium levels closely if combination is necessary.
-
Diuretics and other antihypertensives: additive blood pressure-lowering effects may increase risk of symptomatic hypotension—doses may need adjustment.
-
Azathioprine or other nephrotoxic drugs: combined renal risk may require monitoring.
Always consult the prescribing clinician or pharmacist before starting new prescription or over-the-counter medicines, herbal products, or dietary supplements.
Precautions and Monitoring
-
Baseline and periodic monitoring of blood pressure, renal function (serum creatinine, eGFR), and serum potassium is recommended, particularly after starting therapy or changing dose.
-
Monitor for signs of hypotension in patients with salt or volume depletion (for example, due to diuretics, diarrhea, or vomiting).
-
In patients with renal artery stenosis or other significant renal disease, use with caution and under specialist guidance.
-
Report symptoms such as swelling of face/mouth/throat, severe dizziness, fainting, or decreased urine output immediately.
When to Seek Medical Help
-
Signs of allergic reaction or angioedema: swelling of face, lips, tongue, throat, difficulty breathing or swallowing—seek emergency care.
-
Severe dizziness, fainting, or signs of very low blood pressure.
-
Symptoms of kidney problems: reduced urine output, swelling of legs, unexplained weight gain.
-
Symptoms suggesting hyperkalemia: muscle weakness, persistent palpitations, or unusual tiredness.
Disclaimer
This document summarizes general information about olmesartan medoxomil 20 mg and is not a substitute for individualized medical advice. Dosage, specific indications, and monitoring should be determined by a qualified healthcare professional based on the patient’s clinical condition and comorbidities. If you have questions about suitability, dosing, or interactions, consult your doctor or pharmacist.
| Product Name | Olmesartan Medoxomil Tablets |
| Category | All Medicines, Cardiac / Hypertension |
| Form | Raw Powder |
| Grade | As per available specification |
| Documents | COA, MSDS, Invoice, Packing List |
| Packing | As per order quantity |
| MOQ | On request |
| Shipment | Air cargo / courier / buyer-approved route |
| Use | B2B, formulation, compounding, research & qualified buyer supply |
| Disclaimer | Subject to buyer country regulations |
Additional information
| Strength | 20mg |
|---|
Customer Reviews
Only logged in customers who have purchased this product may leave a review.
